Breast Care Network | Risk Assessment

FEATURED, Risk Assessment, Breast Cancer, Risk

TC

There are numerous breast cancer prediction models, including IBIS/Tyrer-Cuzick (ITC), Gail model, BRCAPRO and, BOADICEA/CanRisk. Of these, ITC and BOADICEA/Can...

FEATURED, Genomics, Industry, Risk Assessment, Genetic Testing

Cyber Monday for Genomic Testing - Whole Genome Sequencing for $199

Ever think you would hear about a holiday special for genomic testing? Veritas Genetics is offering this $999 whole genome testing for the first 1000 people who...

FEATURED, Research, Risk Assessment, Genetic Testing

Do we now start testing patients who have familial BC but not BRCA 1 or 2?

Four Additional Genes Added to the List of Associated Breast Cancer Risk As we do more and more genetic testing with ever expanding panels, we discover more gen...

Is genetic testing is ready for prime time-433780-edited

FEATURED, Risk Assessment, Genetic Testing

Is Genetic Testing Ready for PrimeTime?

Should we start using genetics routinely as a screen for early disease prevention? In an editorial by Dr. Kevin Hughes, he points out the dilemma that we have p...

FEATURED, Genomics, News, Radiation, Regional Management, Risk Assessment

Influence of the subtype on local recurrence risk of breast cancer with or without radiotherapy

Breast Cancer Subtype May Be Predictive of Ipsilateral Breast Tumor Recurrence Studies have shown that certain intrinsic subtypes of breast cancer are associate...

FEATURED, Genomics, News, Risk Assessment, Histology

Standard Light Microscopy Illuminates a Molecular Mystery

Why do triple negative breast cancers in BRCA-1 patients have a better prognosis?

FEATURED, Genetics, News, Risk Assessment, Genetic Testing

Genome-wide Association Studies (GWAS) may be future for helping determine relative risk

Genetics have a thumb on the scale for just about every human trait Francis Collins, current Director of the NIH and member of the Human Genome Project, predic...